Clinical Trials Directory

Trials / Unknown

UnknownNCT04896203

Hypercoagulability Study Using Haemostatic Techniques in Patients With Inflammatory Bowel Disease

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Hospital Universitario La Paz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Descriptive study, in which the haemostatic profile of ambulatory patients with IBD will be analyzed by means of ROTEM and other techniques, such as the thrombin generation test and the study of platelet function by flow cytometry.

Detailed description

Descriptive study, in which the haemostatic profile of ambulatory patients with IBD will be analyzed by rotational thromboelastometry (ROTEM) and other techniques, such as thrombin generation test and platelet function study by flow cytometry. The results of these measurements will be subsequently compared between the different IBD patient groups, stratified by activity and other risk factors, as well as with healthy controls, in order to define in which of these situations a significant prothrombotic risk exists, and which part of the coagulation cascade conditions that risk. After this, we will describe the incidence and prevalence of thromboembolic events in the follow-up of these patient groups. Finally, an attempt will be made to determine, according to the results of the study if any of the situations outside the classic recommendations would be subsidiary to receive chemoprophylaxis for the thromboembolic events. The aim of this study is to determine the possible state of hypercoagulability of ambulatory patients with Inflammatory Bowel Disease, stratified according to the characteristics of their disease, by using ROTEM as well as the thrombin generation test. Platelet function will also be evaluated by flow cytometry.

Conditions

Interventions

TypeNameDescription
PROCEDURErotational thromboelastometryViscoelastometric method useful to study the kinetics of clot formation and fibrinolysis, providing a global information of both the cellular component and the pro and anticoagulant proteins, as well as the interactions between both components.

Timeline

Start date
2020-11-18
Primary completion
2021-12-15
Completion
2022-02-15
First posted
2021-05-21
Last updated
2021-07-23

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04896203. Inclusion in this directory is not an endorsement.